Tadalafil NDC 60290-029

Product information

Brand name (proprietary)

Tadalafil

Generic name (nonproprietary)

tadalafil

Active ingredients

Tadalafil — 10 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Umedica Laboratories USA Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 211298

Marketing start

Feb 15, 2026

Listing expires

Dec 31, 2027

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 60290-029_50582108-5bae-7795-e063-6294a90aa191SPL ID 50582108-5bae-7795-e063-6294a90aa191SPL set ID 6caf3b55-9bf4-4355-9e25-8bf368943fddRxCUI 402019, 403957, 484814, 757707UNII 742SXX0ICTUPC 0360290027027, 0360290028017

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460290002901 followed by a unit qualifier and the quantity Copy

Package 60290-0029-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 211298

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.